Table 1.

Mean survival by chemotherapy

Treatment	Mean survival (years)	Reference
Cisplatin/paclitaxel (CP)	1.1	7
Cisplatin/paclitaxel/bevacizumab (CP+B)	1.35	7
Paclitaxel/topotecan (PT)	1.25	9
Paclitaxel/topotecan/bevacizumab (PT+B)	1.56	7,9